v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 70,047 $ 56,587
General and administrative 17,290 14,796
Total operating expenses 87,337 71,383
Loss from operations (87,337) (71,383)
Interest income (expense), net 4,380 3,160
Other income (expense), net (1) (20)
Net loss and comprehensive loss (82,958) (68,243)
Impact of preferred stock extinguishments and modifications   (6,300)
Net loss attributable to common stockholders $ (82,958) $ (74,543)
Net loss per share attributable to common stockholders, basic $ (2.46) $ (26.91)
Net loss per share attributable to common stockholders, diluted $ (2.46) $ (26.91)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Basic 33,700,550 2,770,352
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Diluted 33,700,550 2,770,352